vimarsana.com
Home
Live Updates
Modalis Therapeutics Reports Data Supporting Development of
Modalis Therapeutics Reports Data Supporting Development of
Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD)
A breakthrough approach and supporting data using epigenome editing technology for the treatment of a type of muscular dystrophy, LAMA2-congenital muscular dystrophy , a genetic disorder, is...
Related Keywords
Tokyo ,
Japan ,
Haru Morita ,
Tokyo Stock Exchange Growth ,
Modalis Therapeutics Corporation Tokyo Stock Exchange ,
,
Modalis Therapeutics Corporation ,
Tokyo Stock Exchange ,
Congenital Muscular Dystrophy ,
Waltham Massachusetts ,
Markets ,